← Open Payments lookup

STACY GILKEY: Open Payments

NPI 1740701978 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$371 in 15 payments from 8 companies in 2025. Trend: 2023 $786 · 2024 $113 · 2025 $371

Food & beverage: $371
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$119
Alkermes, Inc.2$64
Vanda Pharmaceuticals Inc.2$52
Janssen Pharmaceuticals, Inc1$37
Otsuka America Pharmaceutical, Inc.2$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$31
ABBVIE INC.1$17
Neurocrine BioSciences, Inc.1$16

Products named: COBENFY, HETLIOZ, INVEGA SUSTENNA, VIVITROL, CAPLYTA, ARISTADA, REXULTI, VRAYLAR.

Industry payments across KY — which companies pay providers there.